Search Results for:
Frederick R Ball
(86)
ARTICLES(86)
-
Cannabis – Proposed Federal Bill, the CLAIM Act, to ease access to insurance for Cannabis Related Businesses
- March 19, 2021
- LEGAL ALERTS/ARTICLES
-
FDA's Additional Draft Guidance on Biosimilarity and Interchangeability to Seek Comments and Suggestions by January 19, 2021
- December 11, 2020
- LEGAL ALERTS/ARTICLES
-
PBMs Must Say Goodbye to Manufacturer Rebates
- December 07, 2020
- LEGAL ALERTS/ARTICLES
-
HHS OIG Issues Rare Special Fraud Alert Addressing Speaker Programs
- November 30, 2020
- LEGAL ALERTS/ARTICLES
-
Could COVID-19 Data Help Medical Device Manufacturers Accelerate the FDA Approval Process?
- November 09, 2020
- LEGAL ALERTS/ARTICLES
-
FDA Expectations for Inspections of CDER- or CDRH-Led Combination Product Manufacturers Detailed in New FDA Compliance Program
- June 12, 2020
- LEGAL ALERTS/ARTICLES
-
FDA Takes Steps to Enhance Availability of Safe and Effective Face Masks
- April 22, 2020
- LEGAL ALERTS/ARTICLES
-
COVID-19 Treatment Approvals Accelerated by New FDA CTAP Program
- April 03, 2020
- LEGAL ALERTS/ARTICLES
-
FDA Unveils Program to Expedite Coronavirus Treatments
- April 01, 2020
- LEGAL ALERTS/ARTICLES
-
FDA Virtual Town Hall for Laboratories and Manufacturers Developing Diagnostics Tests for COVID-19
- March 31, 2020
- LEGAL ALERTS/ARTICLES
-
Declaration Provides Immunity for Certain COVID-19 Pandemic Medical Countermeasure Activities
- March 18, 2020
- LEGAL ALERTS/ARTICLES
-
FDA Guidance Aims to Accelerate Availability of COVID-19 Tests
- March 18, 2020
- LEGAL ALERTS/ARTICLES
-
A Cannabidiol Catalyst? Recent Events Increase Pressure on FDA to Regulate CBD
- February 01, 2020
- LEGAL ALERTS/ARTICLES
-
U.S. Senators Urge Changes to Testing Requirements Under USDA Interim Final Rule for Hemp Program
- November 22, 2019
- LEGAL ALERTS/ARTICLES
-
Regulatory Uncertainty Hangs Over Production of Industrial Hemp
- November 20, 2019
- LEGAL ALERTS/ARTICLES
-
In a Regulatory "One-Two," FDA Modifies Terms of Oversight Concerning Homeopathic Drugs
- October 31, 2019
- LEGAL ALERTS/ARTICLES
-
FDA’s New Medical Device Rules Speed Up Review Process
- October 03, 2019
- LEGAL ALERTS/ARTICLES
-
FDA's New Medical Device Rules Speed Up Review Process
- October 02, 2019
- LEGAL ALERTS/ARTICLES
-
DEA Announcement on Improving Access to Marijuana Research
- September 03, 2019
- LEGAL ALERTS/ARTICLES
-
Much of Oklahoma’s $572 Million Opioid Case Likely to Be Replicated Elsewhere, But Unique Cause of Action May Not
- August 28, 2019
- LEGAL ALERTS/ARTICLES
-
OTC Personal Products Manufacturer Cited by FDA for Various Regulatory Violations
- August 27, 2019
- LEGAL ALERTS/ARTICLES
-
CMS Issues Proposed Regulations to Expand Open Payments System Reporting
- August 26, 2019
- LEGAL ALERTS/ARTICLES
-
FDA Releases Guidance on REMS Modifications and Revisions
- August 09, 2019
- LEGAL ALERTS/ARTICLES
-
Second Circuit Asks How to Address 924(c) Appeals in the Wake of Davis
- August 07, 2019
- LEGAL ALERTS/ARTICLES
-
FDA Comments on the Public Hearing on Products Containing Cannabis and Cannabis-Derived Compounds and Extends Comment Period
- June 24, 2019
- LEGAL ALERTS/ARTICLES
-
CDER's New MAPP on Risk-Based Site Selection Model for Routine Inspections
- January 15, 2019
- LEGAL ALERTS/ARTICLES
-
FDA Issues Final Guidance on Data Integrity and Compliance with CGMP
- January 14, 2019
- LEGAL ALERTS/ARTICLES
-
DOJ Implements Granston Memo: Motions to Dismiss Filed in 11 False Claims Act Cases
- January 03, 2019
- LEGAL ALERTS/ARTICLES
-
FDA Announces New UDI Compliance Deadlines via Another Guidance Document
- December 27, 2018
- LEGAL ALERTS/ARTICLES